Attached files

file filename
EX-4.24 - THIRD AMENDMENT TO 2011 STOCK INCENTIVE PLAN - Avid Bioservices, Inc.peregrine_10k-ex0424.htm
EX-4.27 - AMENDMENT TO FORM OF STOCK OPTION AWARD AGREEMENT - Avid Bioservices, Inc.peregrine_10k-ex0427.htm
EX-4.22 - FIRST AMENDMENT TO 2005 STOCK INCENTIVE PLAN - Avid Bioservices, Inc.peregrine_10k-ex0422.htm
EX-4.26 - AMENDMENT TO FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT - Avid Bioservices, Inc.peregrine_10k-ex0426.htm
EX-32 - CERTIFICATION - Avid Bioservices, Inc.peregrine_10k-ex32.htm
EX-31.2 - CERTIFICATION - Avid Bioservices, Inc.peregrine_10k-ex3102.htm
EX-31.1 - CERTIFICATION - Avid Bioservices, Inc.peregrine_10k-ex3101.htm
EX-4.25 - AMENDMENT TO FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT - Avid Bioservices, Inc.peregrine_10k-ex0425.htm
EX-21 - SUBSIDIARIES - Avid Bioservices, Inc.peregrine_10k-ex21.htm
10-K - ANNUAL REPORT - Avid Bioservices, Inc.peregrine_10k-043015.htm
EX-4.23 - FIRST AMENDMENT TO 2009 STOCK INCENTIVE PLAN - Avid Bioservices, Inc.peregrine_10k-ex0423.htm

EXHIBIT 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-192794, 333-185423, 333-178452, 333-171067, 333-164026, 333-130271, 333-121334, 333-106385, 333-57046, and 333-17513; Form S-3 Nos. 333-201245 and 333-193113) of Peregrine Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated July 14, 2015, with respect to the consolidated financial statements and schedule of Peregrine Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Peregrine Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended April 30, 2015.

 

 

 

/s/ Ernst & Young LLP

 

Irvine, California

July 14, 2015